Indefinite Delivery Contract SPM20005D0911

This single-award Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group, Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $499,999,999, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract covers various product categories such as injections, tablets, creams, auto-injectors, and specialty medications, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain. The IDC, which is not associated with any set-aside designations, has a period of performance through November 2026 and allows for the direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites located primarily in Park Ridge, Illinois.

The task orders issued under this IDC, valued individually from $36 to $28,402.80, demonstrate the breadth of pharmaceutical products and medical supplies DMS Pharmaceutical Group provides to the DLA and military healthcare facilities. These delivery orders cover a wide range of medications, including specialty drugs like Xolair, Trikafta, Keytruda, Botox, and Nucala, as well as various other prescription drugs, over-the-counter products, and medical consumables necessary to support the recurring medical needs of the Department of Defense.